Giving Matters

With your support, our physicians, researchers, nurses, administrators, and staff are able to provide patients today with the most advanced personalized care and explore new treatment options for the future through research. We invite you to learn more about the many ways your generosity is put to work with programs, patients, and research projects at BIDMC that matter to you. See highlights from our current issue of the Office of Development newsletter, Giving Matters, below:

Investing in the Future of Maternal-Fetal Medicine

Major gift establishes new BIDMC Chair in Ob/Gyn

We are excited to share the news of a truly inspiring $3 million gift from Annie and Chase Koch to create The Annie and Chase Koch Chair in the Department of Obstetrics and Gynecology and launch a transformative program in the Division of Maternal-Fetal Medicine. 

Beating Heart Disease

Robert E. Gerszten, M.D.

During a typical stint in the cardiac intensive care unit, Robert E. Gerszten, M.D., will often evaluate patients experiencing their first heart attack. Many are easy to identify based on traditional risk factors of age, gender, hypertension, high cholesterol levels, or smoking history. But those aren’t the patients that keep the chief of the Division of Cardiovascular Medicine up at night. “The problem is that if you look at the entire segment of people who develop heart disease, lots of them don’t have those risk factors,” he says of the individuals who do not show the traditional warning signs to trigger immediate life saving care. “We need to uncover better risk factors, and we need to understand the biology much better.”

Robert E. Gerszten, M.D.

Breaking the Silence

Advances in care and research shed new light on pancreatic cancer

Pancreatic cancer remains one of the most challenging forms of cancer, with an annual death toll of more than 50,000 in the United States, and a survival rate that has improved little over the past 25 years. With only one-fifth of Americans diagnosed with pancreatic cancer surviving for a full year, it is the third leading cause of cancer death in the country, and that statistic is increasing. “More than 70 percent of Americans with potentially curable early-stage pancreatic cancer aren’t even offered surgery,” says A. James Moser, M.D., co-director of the Pancreas and Liver Institute at Beth Israel Deaconess Medical Center and renowned pancreatic surgeon. “That is how bad the rap is for this disease.”

Manuel Hidalgo, M.D., Ph.D., and A. James Moser, M.D.

Turning Data into Wisdom

Major gift establishes new Harvard Medical School Professorship focused on IT innovation

Ben Zhou, M.D., recalls attending health care information technology (IT) forums around the world. Over two decades, he was always captivated by the same keynote speaker: John Halamka, M.D., M.S., chief information officer of the Beth Israel Deaconess System. Zhou’s immense gratitude for their partnership led him to facilitate a transformational gift of $3.3 million to BIDMC to establish an endowed professorship in honor of Halamka.

John Halamka, M.D., Ben Zhou, M.D.

Thinking Inside the Box

Enterprising researchers design award-winning diagnostic device to make health care access universal

Could a portable toolbox transform health care in rural China? For Chung-Kang “CK” Peng, Ph.D., a statistical physicist at BIDMC, the idea is not so far-fetched. For the past five years, Peng and his international, multidisciplinary team have worked on building just such a contraption as part of the $10 million Qualcomm Tricorder XPRIZE, which challenged contestants to design and construct a compact, wireless, and user-friendly clinical diagnostics device for the lay consumer. 

CK Peng, Ph.D.